194 related articles for article (PubMed ID: 26297384)
1. Functional selectivity of kappa opioid receptor agonists in peripheral sensory neurons.
Jamshidi RJ; Jacobs BA; Sullivan LC; Chavera TA; Saylor RM; Prisinzano TE; Clarke WP; Berg KA
J Pharmacol Exp Ther; 2015 Nov; 355(2):174-82. PubMed ID: 26297384
[TBL] [Abstract][Full Text] [Related]
2. Regulation of κ-opioid receptor signaling in peripheral sensory neurons in vitro and in vivo.
Berg KA; Rowan MP; Sanchez TA; Silva M; Patwardhan AM; Milam SB; Hargreaves KM; Clarke WP
J Pharmacol Exp Ther; 2011 Jul; 338(1):92-9. PubMed ID: 21487072
[TBL] [Abstract][Full Text] [Related]
3. Long-Term Reduction of Kappa Opioid Receptor Function by the Biased Ligand, Norbinaltorphimine, Requires c-Jun N-Terminal Kinase Activity and New Protein Synthesis in Peripheral Sensory Neurons.
Jamshidi RJ; Sullivan LC; Jacobs BA; Chavera TA; Berg KA; Clarke WP
J Pharmacol Exp Ther; 2016 Nov; 359(2):319-328. PubMed ID: 27605628
[TBL] [Abstract][Full Text] [Related]
4. Signaling characteristics and functional regulation of delta opioid-kappa opioid receptor (DOP-KOP) heteromers in peripheral sensory neurons.
Jacobs BA; Pando MM; Jennings EM; Jamshidi RJ; Zamora JC; Chavera TS; Clarke WP; Berg KA
Neuropharmacology; 2019 Jun; 151():208-218. PubMed ID: 30776373
[TBL] [Abstract][Full Text] [Related]
5. Stimulation of peripheral kappa opioid receptors inhibits inflammatory hyperalgesia via activation of the PI3Kγ/AKT/nNOS/NO signaling pathway.
Cunha TM; Souza GR; Domingues AC; Carreira EU; Lotufo CM; Funez MI; Verri WA; Cunha FQ; Ferreira SH
Mol Pain; 2012 Feb; 8():10. PubMed ID: 22316281
[TBL] [Abstract][Full Text] [Related]
6. The effects of kappa-opioid receptor ligands on prepulse inhibition and CRF-induced prepulse inhibition deficits in the rat.
Tejeda HA; Chefer VI; Zapata A; Shippenberg TS
Psychopharmacology (Berl); 2010 Jun; 210(2):231-40. PubMed ID: 20232058
[TBL] [Abstract][Full Text] [Related]
7. Allosterism within
Jacobs BA; Pando MM; Jennings E; Chavera TA; Clarke WP; Berg KA
Mol Pharmacol; 2018 Apr; 93(4):376-386. PubMed ID: 29436492
[TBL] [Abstract][Full Text] [Related]
8. Effects of U50488 and bremazocine on [Ca2+]i and cAMP in naive and tolerant rat ventricular myocytes: evidence of kappa opioid receptor multiplicity in the heart.
Zhang WM; Wu S; Yu XC; Wang HX; Bian JS; Wong TM
J Mol Cell Cardiol; 1999 Feb; 31(2):355-62. PubMed ID: 10093048
[TBL] [Abstract][Full Text] [Related]
9. 2-Methoxymethyl-salvinorin B is a potent kappa opioid receptor agonist with longer lasting action in vivo than salvinorin A.
Wang Y; Chen Y; Xu W; Lee DY; Ma Z; Rawls SM; Cowan A; Liu-Chen LY
J Pharmacol Exp Ther; 2008 Mar; 324(3):1073-83. PubMed ID: 18089845
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the diuretic effects of chemically diverse kappa opioid agonists in rats: nalfurafine, U50,488H, and salvinorin A.
Inan S; Lee DY; Liu-Chen LY; Cowan A
Naunyn Schmiedebergs Arch Pharmacol; 2009 Mar; 379(3):263-70. PubMed ID: 18925386
[TBL] [Abstract][Full Text] [Related]
11. The contribution of activated peripheral kappa opioid receptors (kORs) in the inflamed knee joint to anti-nociception.
Moon SW; Park EH; Suh HR; Ko DH; Kim YI; Han HC
Brain Res; 2016 Oct; 1648(Pt A):11-18. PubMed ID: 27378583
[TBL] [Abstract][Full Text] [Related]
12. Interactive effects of (±)-trans-U50488 and its stereoisomers with cannabinoids.
Erwin LL; Nilges MR; Denys IB; Sutphen JC; Friend AJ; Kapusta DR; Winsauer PJ
Pharmacol Biochem Behav; 2021 Aug; 207():173218. PubMed ID: 34118232
[TBL] [Abstract][Full Text] [Related]
13. Estrogen Regulation of GRK2 Inactivates Kappa Opioid Receptor Signaling Mediating Analgesia, But Not Aversion.
Abraham AD; Schattauer SS; Reichard KL; Cohen JH; Fontaine HM; Song AJ; Johnson SD; Land BB; Chavkin C
J Neurosci; 2018 Sep; 38(37):8031-8043. PubMed ID: 30076211
[TBL] [Abstract][Full Text] [Related]
14. Differential effects of agonists on adenylyl cyclase superactivation mediated by the kappa opioid receptors: adenylyl cyclase superactivation is independent of agonist-induced phosphorylation, desensitization, internalization, and down-regulation.
Wang Y; Li JG; Huang P; Xu W; Liu-Chen LY
J Pharmacol Exp Ther; 2003 Dec; 307(3):1127-34. PubMed ID: 14557376
[TBL] [Abstract][Full Text] [Related]
15. Quantification of observable behaviors induced by typical and atypical kappa-opioid receptor agonists in male rhesus monkeys.
Huskinson SL; Platt DM; Brasfield M; Follett ME; Prisinzano TE; Blough BE; Freeman KB
Psychopharmacology (Berl); 2020 Jul; 237(7):2075-2087. PubMed ID: 32372348
[TBL] [Abstract][Full Text] [Related]
16. Reactive oxygen species (ROS) generation is stimulated by κ opioid receptor activation through phosphorylated c-Jun N-terminal kinase and inhibited by p38 mitogen-activated protein kinase (MAPK) activation.
Schattauer SS; Bedini A; Summers F; Reilly-Treat A; Andrews MM; Land BB; Chavkin C
J Biol Chem; 2019 Nov; 294(45):16884-16896. PubMed ID: 31575661
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the discriminative stimulus effects of salvinorin A and its derivatives to U69,593 and U50,488 in rats.
Baker LE; Panos JJ; Killinger BA; Peet MM; Bell LM; Haliw LA; Walker SL
Psychopharmacology (Berl); 2009 Apr; 203(2):203-11. PubMed ID: 19153716
[TBL] [Abstract][Full Text] [Related]
18. U50488 inhibits HIV-1 expression in acutely infected monocyte-derived macrophages.
Chao CC; Gekker G; Sheng WS; Hu S; Peterson PK
Drug Alcohol Depend; 2001 Apr; 62(2):149-54. PubMed ID: 11245971
[TBL] [Abstract][Full Text] [Related]
19. Salvinorin A, an active component of the hallucinogenic sage salvia divinorum is a highly efficacious kappa-opioid receptor agonist: structural and functional considerations.
Chavkin C; Sud S; Jin W; Stewart J; Zjawiony JK; Siebert DJ; Toth BA; Hufeisen SJ; Roth BL
J Pharmacol Exp Ther; 2004 Mar; 308(3):1197-203. PubMed ID: 14718611
[TBL] [Abstract][Full Text] [Related]
20. Effect of kappa-opioid receptor agonists U69593, U50488H, spiradoline and salvinorin A on cocaine-induced drug-seeking in rats.
Morani AS; Kivell B; Prisinzano TE; Schenk S
Pharmacol Biochem Behav; 2009 Dec; 94(2):244-9. PubMed ID: 19747933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
